APA 6th Edition Vučić Lovrenčić, M., Smirčić Duvnjak, L. i Rahelić, D. (2015). HEMOGLOBIN A1c I KVALITETA SKRBI ZA OBOLJELE OD ŠEĆERNE BOLESTI. Liječnički vjesnik, 137 (9-10), 0-0. Preuzeto s https://hrcak.srce.hr/172723
MLA 8th Edition Vučić Lovrenčić, Marijana, et al. "HEMOGLOBIN A1c I KVALITETA SKRBI ZA OBOLJELE OD ŠEĆERNE BOLESTI." Liječnički vjesnik, vol. 137, br. 9-10, 2015, str. 0-0. https://hrcak.srce.hr/172723. Citirano 21.10.2019.
Chicago 17th Edition Vučić Lovrenčić, Marijana, Lea Smirčić Duvnjak i Dario Rahelić. "HEMOGLOBIN A1c I KVALITETA SKRBI ZA OBOLJELE OD ŠEĆERNE BOLESTI." Liječnički vjesnik 137, br. 9-10 (2015): 0-0. https://hrcak.srce.hr/172723
Harvard Vučić Lovrenčić, M., Smirčić Duvnjak, L., i Rahelić, D. (2015). 'HEMOGLOBIN A1c I KVALITETA SKRBI ZA OBOLJELE OD ŠEĆERNE BOLESTI', Liječnički vjesnik, 137(9-10), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172723 (Datum pristupa: 21.10.2019.)
Vancouver Vučić Lovrenčić M, Smirčić Duvnjak L, Rahelić D. HEMOGLOBIN A1c I KVALITETA SKRBI ZA OBOLJELE OD ŠEĆERNE BOLESTI. Liječnički vjesnik [Internet]. 2015 [pristupljeno 21.10.2019.];137(9-10):0-0. Dostupno na: https://hrcak.srce.hr/172723
IEEE M. Vučić Lovrenčić, L. Smirčić Duvnjak i D. Rahelić, "HEMOGLOBIN A1c I KVALITETA SKRBI ZA OBOLJELE OD ŠEĆERNE BOLESTI", Liječnički vjesnik, vol.137, br. 9-10, str. 0-0, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/172723. [Citirano: 21.10.2019.]
Sažetak Global diabetes epidemics is currently representing one of the most prominent medical and societal challenges. Hemoglobin A1c (HbA1c), a biochemical marker of an average blood glucose concentration has been used for more than 30 years as a clinical indicator of both diabetes treatment efficacy and the risk for development of complications. Recently, HbA1c was proposed as a diabetes diagnostic test as well. Regular monitoring of glycemic control and adjustment of
therapy towards the recommended HbA1c-based treatment-goals is a pivotal request of contemporary diabetes care guidelines, as well as a quality indicator proclaimed by numerous national health-care-delivery systems. Standardized and attainable analytical methodology of high-quality and a good knowledge on determinants of biological variability, able to influence test results, are crucial elements for the confident clinical use of HbA1c. In this review, essential analytical and clinical aspects necessary for the reliable use of HbA1c results in diabetes care are concisely presented, together with the degree of Croatian laboratory and clinical practice harmonization with the relevant international standards.